220 related articles for article (PubMed ID: 30357458)
21. Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer.
Liu JF; Wu L; Yang LL; Deng WW; Mao L; Wu H; Zhang WF; Sun ZJ
J Exp Clin Cancer Res; 2018 Mar; 37(1):44. PubMed ID: 29506555
[TBL] [Abstract][Full Text] [Related]
22. Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancer.
Gadwa J; Bickett TE; Darragh LB; Knitz MW; Bhatia S; Piper M; Van Court B; Bhuvane S; Nguyen D; Nangia V; Kleczko EK; Nemenoff RA; Karam SD
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33789881
[TBL] [Abstract][Full Text] [Related]
23. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
[TBL] [Abstract][Full Text] [Related]
24. Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients.
Jie HB; Gildener-Leapman N; Li J; Srivastava RM; Gibson SP; Whiteside TL; Ferris RL
Br J Cancer; 2013 Nov; 109(10):2629-35. PubMed ID: 24169351
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous and oral squamous cell carcinoma-dual immunosuppression via recruitment of FOXP3+ regulatory T cells and endogenous tumour FOXP3 expression?
Schipmann S; Wermker K; Schulze HJ; Kleinheinz J; Brunner G
J Craniomaxillofac Surg; 2014 Dec; 42(8):1827-33. PubMed ID: 25087653
[TBL] [Abstract][Full Text] [Related]
26. The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer.
Pastille E; Wasmer MH; Adamczyk A; Vu VP; Mager LF; Phuong NNT; Palmieri V; Simillion C; Hansen W; Kasper S; Schuler M; Muggli B; McCoy KD; Buer J; Zlobec I; Westendorf AM; Krebs P
Mucosal Immunol; 2019 Jul; 12(4):990-1003. PubMed ID: 31165767
[TBL] [Abstract][Full Text] [Related]
27. Gastric cancer cells induce human CD4+Foxp3+ regulatory T cells through the production of TGF-β1.
Yuan XL; Chen L; Zhang TT; Ma YH; Zhou YL; Zhao Y; Wang WW; Dong P; Yu L; Zhang YY; Shen LS
World J Gastroenterol; 2011 Apr; 17(15):2019-27. PubMed ID: 21528082
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of Treg/Th17 According to Cancer Progression and Modification in Biliary Tract Cancers via Self-Producing Cytokines.
Kinoshita M; Kobayashi S; Gotoh K; Kubo M; Hayashi K; Iwagami Y; Yamada D; Akita H; Noda T; Asaoka T; Takeda Y; Tanemura M; Eguchi H; Urakawa S; Goto K; Maekawa K; Wada H; Mori M; Doki Y
Dig Dis Sci; 2020 Oct; 65(10):2937-2948. PubMed ID: 31853779
[TBL] [Abstract][Full Text] [Related]
29. Quantification of tumor infiltrating Foxp3+ regulatory T cells enables the identification of high-risk patients for developing synchronous cancers over upper aerodigestive tract.
Wang WL; Chang WL; Yang HB; Chang IW; Lee CT; Chang CY; Lin JT; Sheu BS
Oral Oncol; 2015 Jul; 51(7):698-703. PubMed ID: 25958829
[TBL] [Abstract][Full Text] [Related]
30. Dynamics of regulatory T cells (T
Aggarwal S; Sharma SC; N Das S
J Surg Oncol; 2017 Dec; 116(8):1103-1113. PubMed ID: 28833201
[TBL] [Abstract][Full Text] [Related]
31. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
[TBL] [Abstract][Full Text] [Related]
32. Functionally distinct subsets of CD4⁺ regulatory T cells in patients with laryngeal squamous cell carcinoma are indicative of immune deregulation and disease progression.
Sun W; Li WJ; Fu QL; Wu CY; Lin JZ; Zhu XL; Hou WJ; Wei Y; Wen YH; Wang YJ; Wen WP
Oncol Rep; 2015 Jan; 33(1):354-62. PubMed ID: 25333227
[TBL] [Abstract][Full Text] [Related]
33. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
[TBL] [Abstract][Full Text] [Related]
34. Blockade of MCP-1/CCR4 signaling-induced recruitment of activated regulatory cells evokes an antitumor immune response in head and neck squamous cell carcinoma.
Sun W; Li WJ; Wei FQ; Wong TS; Lei WB; Zhu XL; Li J; Wen WP
Oncotarget; 2016 Jun; 7(25):37714-37727. PubMed ID: 27177223
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a Helicobacter pylori model of gastric cancer.
Lin R; Ma H; Ding Z; Shi W; Qian W; Song J; Hou X
Stem Cells Dev; 2013 Nov; 22(21):2836-48. PubMed ID: 23777268
[TBL] [Abstract][Full Text] [Related]
36. Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory t cells in human head and neck carcinoma during radio-chemotherapy.
Schuler PJ; Börger V; Bölke E; Habermehl D; Matuschek C; Wild CA; Greve J; Bas M; Schilling B; Bergmann C; Trellakis S; Budach W; Gauler T; Brandau S; Lang S; Whiteside TL; Sorg RV; Hoffmann TK
Eur J Med Res; 2011 Feb; 16(2):57-62. PubMed ID: 21463982
[TBL] [Abstract][Full Text] [Related]
37. FoxP3
Saleh R; Elkord E
Cancer Lett; 2020 Oct; 490():174-185. PubMed ID: 32721551
[TBL] [Abstract][Full Text] [Related]
38. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.
Younis RH; Han KL; Webb TJ
J Immunol; 2016 Feb; 196(3):1419-29. PubMed ID: 26740106
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of ST2 on regulatory T cells is associated with cancer associated fibroblast-derived IL-33 in laryngeal cancer.
Zhao Y; Sun J; Liang Y; Jiang X; Tang X; Sun Y; Xu C; Wan G; Sun J; Pan C
Pathol Res Pract; 2022 Sep; 237():154023. PubMed ID: 35908385
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.
Badoual C; Hans S; Rodriguez J; Peyrard S; Klein C; Agueznay Nel H; Mosseri V; Laccourreye O; Bruneval P; Fridman WH; Brasnu DF; Tartour E
Clin Cancer Res; 2006 Jan; 12(2):465-72. PubMed ID: 16428488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]